ArticleDigital health
Association between BMI and dyslipidemia in patients with severe mental disorders: An electronic health record study.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: It's well known that obesity is a significant risk factor for dyslipidemia in the general population, but research related to individuals with mental disorders remains scarce. This study aimed to investigate the association between body mass index (BMI) and dyslipidemia among adult patients with severe mental disorders (SMD). Methods: We implemented a cross-sectional study based on electronic health records. A total of 1145 adult SMD patients who underwent health examinations in 2022 were selected as study subjects. The multivariate logistic regression was used to explore association between BMI and dyslipidemia (including specific lipid abnormalities), and the exposure-response curves were plotted for whole population and subgroups. Results: Among the study subjects, 574 SMD patients had dyslipidemia. Compared with patients of normal weight, underweight was negatively associated with dyslipidemia ( Conclusions: In the management of SMD patients, it is crucial to strengthen weight control and implement targeted interventions based on individual characteristics and specific types of dyslipidemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.